Keqin Hua

发表

Exosome Mediated Cytosolic Cisplatin Delivery Through Clathrin-Independent Endocytosis and Enhanced Anti-cancer Effect via Avoiding Endosome Trapping in Cisplatin-Resistant Ovarian Cancer

W. Liu, Jingxin Ding, Yu-Fan Gu, 2022, Frontiers in Medicine.

Assessment of ESGO Quality Indicators in Cervical Cancer Surgery: A Real-World Study in a High-Volume Chinese Hospital

Xuyin Zhang, J. Qiu, Keqin Hua, 2022, Frontiers in Oncology.

Factors Associated with Patient Survival in Clear Cell Adenocarcinoma of the Cervix: A Single-Center Experience in China

Keqin Hua, Ting Wang, Zhiying Lu, 2022, International journal of general medicine.

HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis

Jingxin Ding, Guannan Zhou, Keqin Hua, 2022, Journal of oncology.

Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort

Xuyin Zhang, Keqin Hua, Yan Ding, 2022, Discover Oncology.

A novel Silva pattern-based model for precisely predicting recurrence in intermediate-risk cervical adenocarcinoma patients

J. Qiu, Chenyan Guo, Keqin Hua, 2022, BMC Women's Health.

LncRNA-LA16c-313D11.11,A Signature to Predict Endometrial Carcinoma Patients with a Better Survival

Keqin Hua, Weijuan Xin, Songping Liu, 2022, Reproductive Sciences.

Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes

Chunbo Li, Keqin Hua, K. Hua, 2022, Frontiers in Immunology.

Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer

Shiming Yang, Hao Wu, Chunbo Li, 2022, Communications Biology.

Mitochondria-Targeted Mesoporous Organic Silica Nanoplatforms for Overcoming Cisplatin Resistance by Disturbing Mitochondrial Redox Homeostasis

J. Qiu, B. Lv, Keqin Hua, 2022, Frontiers in Chemistry.

Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a randomized controlled trial (C-PACC trial)

Y. Teng, J. Qiu, Yudong Wang, 2022, Journal of gynecologic oncology.

Comparison of two different methods for cervicovaginal reconstruction: a long-term follow-up

Xuyin Zhang, Jingxin Ding, Keqin Hua, 2022, International Urogynecology Journal.

CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors

Hongyan Wang, J. Qiu, Qingguo Zhao, 2021, Theranostics.

Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis

Keqin Hua, Chunbo Li, Danyang Liu, 2022, Frontiers in Immunology.

Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer

Xuyin Zhang, J. Qiu, Yan Ding, 2022, Archives of Gynecology and Obstetrics.

Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health

Jingxin Ding, Guannan Zhou, Fangyue Zhou, 2022, Frontiers in Endocrinology.

Artificial intelligence: A powerful paradigm for scientific research

Jialiang Yang, S. Dietmann, J. Tiedje, 2021, Innovation.

LncRNA-LA16c-313D11.11,A Signature to Predict Endometrial Carcinoma Patients with a Better Survival

Keqin Hua, Weijuan Xin, Songping Liu, 2022, Reproductive Sciences.

Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1/PD-L1 blockade immunotherapeutic response in cervical cancer

Bin Lv, J. Qiu, Chenyan Guo, 2022, Oncoimmunology.

Single‐Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus‐Associated (HPVA) and Non‐HPVA Adenocarcinoma

J. Qiu, Chenyan Guo, B. Lv, 2023, Advanced science.

OTT_A_209784 6145..6156

J. Qiu, Xiaoyan Tang, Xiao-jing Lin, 2019 .

Scrutinizing high‐risk patients from ASC‐US cytology via a deep learning model

Chuanfeng Lv, G. Xie, X. Tao, 2022, Cancer cytopathology.

Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer

J. Qiu, Congwen Wang, Meng Zhang, 2022, Journal for ImmunoTherapy of Cancer.

Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors

Hua Jiang, Guofu Zhang, He Zhang, 2022, Journal of Ovarian Research.

Adipocytes-Derived Extracellular Vesicle-miR-26b Promotes Apoptosis of Cumulus Cells and Induces Polycystic Ovary Syndrome

Jingxin Ding, Ligang Wu, Guannan Zhou, 2022, Frontiers in Endocrinology.

Nomogram Predicting Lymph Node Metastasis in the Early-Stage Cervical Cancer

Shiming Yang, Chunbo Li, Keqin Hua, 2022, Frontiers in Medicine.

Partial Reconstruction of Uterus Cervix in Rat by Decellularized Human Uterine Cervical Scaffold Combined with Adipose-Derived Stem Cells (ADSCs)

Xuyin Zhang, Chunbo Li, Keqin Hua, 2022, Journal of immunology research.

Spatiotemporally deciphering the mysterious mechanism of persistent HPV‐induced malignant transition and immune remodelling from HPV‐infected normal cervix, precancer to cervical cancer: Integrating single‐cell RNA‐sequencing and spatial transcriptome

J. Qiu, Xiaoyan Tang, Chenyan Guo, 2023, Clinical and translational medicine.

The biological roles of CD24 in ovarian cancer: old story, but new tales

Jingxin Ding, Guannan Zhou, Keqin Hua, 2023, Frontiers in Immunology.

Vaginal Microbial Environment Skews Macrophage Polarization and Contributes to Cervical Cancer Development

Jingxin Ding, Guannan Zhou, Fangyue Zhou, 2022, Journal of immunology research.

The role of long noncoding RNA H19 in gynecological pathologies: Insights into gene regulation and immune modulation (Review)

Keqin Hua, Yue Wang, Weijuan Xin, 2023, International journal of molecular medicine.

Diverse intratumoral heterogeneity and immune microenvironment of two HPV‐related cervical cancer types revealed by single‐cell RNA sequencing

Yan Ding, Keqin Hua, Chunbo Li, 2023, Journal of medical virology.